Since endostatin is formed by proteolytic degradation of collagen type XVIII by MMP9 (27), our observation of higher plasma endostatin in patients with asymptomatic lymphoma suggests that increased angiogenic activity is an early event in indolent B-NHL progression. The gene discussed is MMP9; the disease is lymphoma.